Dirlotapide

Dirlotapide is a drug used to treat obesity in dogs. It is manufactured by Pfizer and marketed as Slentrol.

Additional recommended knowledge

Daily Sensitivity Test

Weighing the right way

Essential Laboratory Skills Guide

It works as a selective microsomal triglyceride transfer protein inhibitor. This blocks the assembly and release of lipoproteins into the bloodstream, thereby reducing fat absorption. It also elicits a satiety signal from lipid-filled cells lining the intestine.

It is supplied as an oral solution. It is not intended for use in humans or cats.

On January 5 2007, the FDA approved Slentrol, the first time the FDA has approved a drug for obese dogs.^[1]

References

1. ^ FDA approves 1st drug for obese dogs. Yahoo. Retrieved on 2007-01-06.